Cannabinoids inhibit migration of microglial-like cells to the HIV protein Tat

Daniel Fraga1, Erinn S Raborn, Gabriela A Ferreira

  • 1Department of Microbiology and Immunology, School of Medicine, Virginia Commonwealth University, 1101 E. Marshall St., Richmond, VA 23298, USA.

Insights

Cannabinoids like THC reduce microglial cell migration towards HIV Tat protein by activating the CB2 receptor. This suggests cannabinoids may help manage HIV-related neuroinflammation by controlling microglial movement.

Area of Science:

  • Neuroimmunology
  • Pharmacology
  • Virology

Background:

  • Microglia, the immune cells of the central nervous system (CNS), release inflammatory factors, including HIV Tat protein, contributing to HIV neuropathogenesis.
  • HIV Tat protein stimulates microglial migration via beta-chemokine receptors, exacerbating neuroinflammation.
  • Cannabinoids possess anti-inflammatory properties and can cross the blood-brain barrier, offering potential therapeutic avenues for neuroimmune disorders.

Purpose of the Study:

  • To investigate the effects of specific cannabinoids on microglial cell migration induced by HIV Tat protein.
  • To determine the role of cannabinoid receptors, specifically CB1R and CB2R, in mediating these effects.

Main Methods:

  • Utilized a mouse BV-2 microglial cell model to assess migration towards Tat.
  • Administered exogenous cannabinoids (Delta-9-tetrahydrocannabinol [THC], CP55940) and an endogenous cannabinoid (2-arachidonoylglycerol [2-AG]).
  • Employed CB1R and CB2R antagonists (SR141716A, SR144528) and CB2R knockdown via small interfering RNA (siRNA) to elucidate receptor involvement.
  • Analyzed changes in the beta-chemokine receptor CCR-3 expression and localization.

Main Results:

  • Exogenous and endogenous cannabinoids significantly reduced BV-2 cell migration towards Tat in a concentration-dependent manner.
  • The inhibitory effect was blocked by the CB2R antagonist SR144528 but not by the CB1R antagonist SR141716A.
  • CB2R knockdown reversed the cannabinoid-mediated inhibition of migration.
  • Cannabinoid treatment altered the expression and intracellular compartmentation of the beta-chemokine receptor CCR-3.

Conclusions:

  • Cannabinoid-mediated inhibition of microglial migration to HIV Tat is functionally linked to the CB2 receptor.
  • Activation of CB2R by cannabinoids modulates the expression and localization of CCR-3, impacting microglial response to Tat.
  • These findings highlight the therapeutic potential of CB2R-targeting cannabinoids in managing HIV-associated neuroinflammation.

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Chemotherapy-Induced Nausea and Vomiting: Cannabinoids01:21

Chemotherapy-Induced Nausea and Vomiting: Cannabinoids

Tetrahydrocannabinol (THC) is a phytocannabinoid that primarily interacts with the CB1 receptor, a type of G protein-coupled receptor (GPCR) predominantly in and around the chemoreceptor trigger zone (CTZ) and emetic center. THC also blocks the serotonin receptor activity in the dorsal vagal complex (DVC) by inhibiting serotonin release. THC exerts its anti-emetic effects through these interactions, which are beneficial for patients undergoing chemotherapy.
Two synthetic agonists of THC,...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Microtubule Associated Proteins (MAPs)01:42

Microtubule Associated Proteins (MAPs)

Microtubule function and architecture are regulated by an array of specialized proteins called microtubule-associated proteins or MAPs. These proteins are widespread across different organisms and have conserved protein motifs, like the multi-TOG domain for tubulin binding found in the CLASP family of MAPs. Some MAPs are lineage-specific based on their conserved domains. Their functions depend upon the cytoskeletal architecture and cell type they are located within. In-plant cells, a specific...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...